Sofinnova Partners raises €165m for sophomore biotech fund
The fund’s investors include Amgen, Bristol Myers Squibb, and Pfizer Ventures.
The fund’s investors include Amgen, Bristol Myers Squibb, and Pfizer Ventures.
Copyright PEI Media
Not for publication, email or dissemination
